Literature DB >> 3005778

Additional c-abl/bcr rearrangements in a CML patient exhibiting two ph1 chromosomes during blast crisis.

C R Bartram, A de Klein, A Hagemeijer, F Carbonell, E Kleihauer, G Grosveld.   

Abstract

Recent data suggest that two human genes, c-abl on chromosome 9 and bcr on chromosome 22, are involved in the generation of Ph1-positive CML. To examine a possible role of these sequences in transition from chronic towards blastic phase, rearrangements within bcr were analysed in 4 patients with Ph1-positive CML during chronic and acute phase. In 3 patients bcr rearrangements were identical in both phases, while in a fourth patient with duplicated Ph1 an amplified additional bcr fragment was detected in acute phase. Northern blot analysis of blast cells of the latter patient showed a novel 10.3 kb RNA species that replaced the altered 8 kb RNA transcript usually found in Ph1-positive CML.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005778     DOI: 10.1016/0145-2126(86)90045-7

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  N-myc amplification and its relationship to experimental therapy.

Authors:  A Livingstone; R J Mairs
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

2.  Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  A L Hooberman; J J Carrino; D Leibowitz; J D Rowley; M M Le Beau; Z A Arlin; C A Westbrook
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  Persistence of chronic myelocytic leukemia despite deletion of rearranged bcr/c-abl sequences in blast crisis.

Authors:  C R Bartram; J W Janssen; R Becher; A de Klein; G Grosveld
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

4.  Philadelphia chromosome-positive chronic myelogenous leukemia with deleted fusion of BCR and ABL genes.

Authors:  K Ohyashiki; J H Ohyashiki; H Iwabuchi; T Tauchi; A Iwabuchi; K Toyama
Journal:  Jpn J Cancer Res       Date:  1990-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.